Search Results - "Cho, Kyuyong"

1462-P: Effect of Energy Restriction on the Intracellular Metabolism of Rodent Pancreatic ß-Cells In Vitro and Obese Mice by CHIBA, KOKI, NOMOTO, HIROSHI, IZUMIHARA, RIMI, KAMEDA, HIRAKU, CHO, KYUYONG, MIYOSHI, HIDEAKI, ATSUMI, TATSUYA

“…Background: In pancreatic β-cells under diabetic conditions, metabolic stressors cause mitochondrial dysfunction and reduce oxidative phosphorylation,…”
Get full text

116-OR: Changes in Glucose Tolerance and Related Factors after Renal Transplantation in Recipients with Impaired Glucose Tolerance by KUSUMI, MAIKO, NAKAMURA, AKINOBU, MIYA, AIKA, NOMOTO, HIROSHI, KAMEDA, HIRAKU, CHO, KYUYONG, HOTTA, KIYOHIKO, SHINOHARA, NOBUO, MIYOSHI, HIDEAKI, ATSUMI, TATSUYA

“…Background and Aims: Our previous study revealed that more than half of patients with impaired glucose tolerance (IGT) before renal transplantation improved to…”
Get full text

1465-P: Metabolic Remodeling in Pancreatic Beta Cells in Japanese Patients with Type 2 Diabetes by IZUMIHARA, RIMI, NOMOTO, HIROSHI, CHIBA, KOKI, KAMEDA, HIRAKU, CHO, KYUYONG, NAKAMURA, AKINOBU, MIYOSHI, HIDEAKI, MIZUKAMI, HIROKI, ATSUMI, TATSUYA

“…Background and Aims: It has been shown that metabolic remodeling from oxidative phosphorylation to glycolysis via activation of…”
Get full text

1145-P: SGLT2 Inhibitors Improve Day-to-Day Glucose Variability in Patients with Type 1 Diabetes by CHIBA, KOKI, CHO, KYUYONG, KAMEDA, HIRAKU, NAKAMURA, AKINOBU, SHIBAYAMA, YUI, NOMOTO, HIROSHI, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI

“…Background: SGLT2 inhibitors (SGLT2i) are used worldwide, because of their multiple benefits for patients with type 2 diabetes. The purpose of this study was…”
Get full text

7-LB: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with Type 2 Diabetes and Hypertension: A Multicenter, Prospective, Randomized, Open-Label, Parallel-Group Comparison Trial by HASHIMOTO-KAMEDA, REINA, CHO, KYUYONG, NOMOTO, HIROSHI, NAKAMURA, AKINOBU, OMORI, KAZUNO, KAWATA, SHINICHIRO, KAMEDA, HIRAKU, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI

“…Objective: Sodium-glucose cotransporter-2 inhibitor (SGLT2i) treatment had the effect of reducing blood pressure (BP) and cardiovascular events in recent…”
Get full text

120-OR: Hepatic Steatosis Is Inversely Associated with Improvement of Pancreatic Beta-Cell Function after Vertical Sleeve Gastrectomy in Patients with Type 2 Diabetes by NAKAMURA, AKINOBU, OE, YUKI, KUSUMI, MAIKO, MIYA, AIKA, NOMOTO, HIROSHI, KAMEDA, HIRAKU, CHO, KYUYONG, OGAWA, KOJI, EBIHARA, YUMA, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI

“…Background: Improvement of beta-cell function is reportedly involved in the improvement of glucose tolerance and remission of diabetes after bariatric and…”
Get full text

686-P: Unstable Glucose Variability in Type 2 Diabetes Patients with Small Abdominal Visceral Fat Area and Impaired Endogenous Insulin Secretion by MIYA, AIKA, NAKAMURA, AKINOBU, NOMOTO, HIROSHI, KAMEDA, HIRAKU, CHO, KYUYONG, NAGAI, SO, ITO, YOICHI M., MIYOSHI, HIDEAKI, ATSUMI, TATSUYA

“…Background: Impaired endogenous insulin secretion was related to instability of glucose variability (GV) in patients with type 2 diabetes (T2DM) in our…”
Get full text

1424-P: Impact of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in Obese Patients with Type 2 Diabetes: Prospective Observational Study by OE, YUKI, TAKASE, TAKAHIRO, CHO, KYUYONG, OGAWA, KOJI, EBIHARA, YUMA, MIYA, AIKA, NOMOTO, HIROSHI, KAMEDA, HIRAKU, NAKAMURA, AKINOBU, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI

“…Background: Bariatric/metabolic surgery is a valid treatment option for patients with obesity, type 2 diabetes (T2DM) and nonalcoholic fatty liver disease…”
Get full text

2361-PUB: Enhancement of Flattening Glycemic Fluctuation in Patients with Type 2 Diabetes by SGLT2 Inhibitor Combined with DPP-4 Inhibitor by CHO, KYUYONG, NOMOTO, HIROSHI, NAKAMURA, AKINOBU, OMORI, KAZUNO, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI

“…Background and Aim: DPP-4 inhibitor is well known to flatten glucose fluctuation in patients with type 2 diabetes by exerting a hypoglycemic effect according…”
Get full text

1855-P: Effects of Dapagliflozin and/or Insulin Glargine on Hepatic Steatosis in db/db Mice by OMORI, KAZUNO, NAKAMURA, AKINOBU, MIYOSHI, HIDEAKI, NOMOTO, HIROSHI, KAMEDA, HIRAKU, CHO, KYUYONG, TERAUCHI, YASUO, ATSUMI, TATSUYA

“…Background: Although several studies have shown that SGLT2 inhibitors exert ameliorating effects on hepatic steatosis, the mechanism remains unknown…”
Get full text

2101-P: Adipose Tissue Insulin Resistance in Overweight and Lean Patients with Impaired Glucose Tolerance or Type 2 Diabetes by MIYA, AIKA, NAKAMURA, AKINOBU, KAMEDA, HIRAKU, CHO, KYUYONG, MIYOSHI, HIDEAKI, ATSUMI, TATSUYA

“…Background: When adipose tissue shows insulin resistance, insulin is unable to suppress lipolysis. Several Western studies have revealed a relationship between…”
Get full text

1993-P: Impact of Laparoscopic Sleeve Gastrectomy on Glycemic Control in Japanese Patients with Obesity and Type 2 Diabetes by OE, YUKI, TAKASE, TAKAHIRO, CHO, KYUYONG, NAKAMURA, AKINOBU, NOMOTO, HIROSHI, KAMEDA, HIRAKU, ATSUMI, TATSUYA, MIYOSHI, HIDEAKI

“…Background and Aims: Metabolic surgery has been proven to be effective for improving long-term outcome in patients with obesity and T2DM in Western countries…”
Get full text

2084-P: Hepatic Fat Accumulation Underlies the Inability of Glucokinase Activator to Achieve a Sustained Hypoglycemic Effect in db/db Mice by KAWATA, SHINICHIRO, NAKAMURA, AKINOBU, MIYOSHI, HIDEAKI, TSUCHIDA, KAZUHISA, OMORI, KAZUNO, TAKAHASHI, KIYOHIKO, NOMOTO, HIROSHI, KAMEDA, HIRAKU, CHO, KYUYONG, TERAUCHI, YASUO, ATSUMI, TATSUYA

“…Background: Previous clinical trials have demonstrated that glucokinase activators (GKAs) do not achieve a sustained hypoglycemic effect; however, the…”
Get full text

780-P: Improved Mitochondrial Function by Luseogliflozin Prevents Pancreatic Beta-Cell Damage by YAMAUCHI, YUKI, NAKAMURA, AKINOBU, YOKOTA, TAKASHI, TAKAHASHI, KIYOHIKO, KAWATA, SHINICHIRO, TSUCHIDA, KAZUHISA, OMORI, KAZUNO, NOMOTO, HIROSHI, KAMEDA, HIRAKU, CHO, KYUYONG, ANZAI, TOSHIHISA, TANAKA, SHINYA, TERAUCHI, YASUO, MIYOSHI, HIDEAKI, ATSUMI, TATSUYA

“…We previously showed a sodium glucose co-transporter 2 (SGLT2) inhibitor, luseogliflozin, increased beta cell mass and improved beta cell function in db/db…”
Get full text

SAT040 Administration Of A DHCR24 Inhibitor Reduces The Excessive Adrenal Steroidogenesis In db/db Mice Through Effects The Alteration Of Intracellular Cholesterol Metabolism by Kamigaki, Risa, Kameda, Hiraku, Shibayama, Yui, Nomoto, Hiroshi, Cho, KyuYong, Nakamura, Akinobu, Jin, Shigeki, Matoba, Kotaro, Miyoshi, Hideaki, Atsumi, Tatsuya

“…Disclosure: R. Kamigaki: None. H. Kameda: None. Y. Shibayama: None. H. Nomoto: None. K. Cho: None. A. Nakamura: None. S. Jin: None. K. Matoba: None. H…”
Get full text

Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus by Miyoshi, Arina, Nagai, So, Takeda, Masamitsu, Kondo, Takuma, Nomoto, Hiroshi, Kameda, Hiraku, Hirai, Amiko, Cho, Kyuyong, Kimachi, Kimihiko, Shimizu, Chikara, Atsumi, Tatsuya, Miyoshi, Hideaki

“…Aims/Introduction Polycystic ovary syndrome (PCOS) is a heterogeneous disorder including polycystic ovary morphology (PCOM), ovulatory dysfunction and…”
Get full text